Molbio Diagnostics IPO Subscription Status
The Molbio Diagnostics IPO has been subscribed 70.26x times overall. Retail investors have shown interest with bids for 12.96x the shares available. The Non-Institutional Investor (NII) category has been subscribed 49.8x. Within NII, Big HNI (B-HNI) subscribed 50.82x and Small HNI (S-HNI) subscribed 47.76x. Qualified Institutional Buyers (QIBs) have subscribed 186.39x. Data last updated on 08 Sep, 01:37 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 10 Aug, 2026 and closes on 12 Aug, 2026. The shares are expected to list on stock exchanges on 17 Aug, 2026.
Table of Contents
26,07,168 applications
Live Bidding
| Category | Offered | Applied | Amount (Cr) | Bid Details | TIMES |
|---|---|---|---|---|---|
|
QIB
|
23,25,145 | 43,33,82,148 | 34,973.94 Cr |
43,33,82,148
of 23,25,145
139 applications
34,973.94 Cr
|
186.39x |
|
NII
|
17,43,860 | 8,68,40,604 | 7,008.04 Cr |
8,68,40,604
of 17,43,860
1,52,244 applications
7,008.04 Cr
|
49.8x |
|
Retail
|
40,69,005 | 5,27,19,318 | 4,254.45 Cr |
5,27,19,318
of 40,69,005
24,54,316 applications
4,254.45 Cr
|
12.96x |
|
Employee
|
20,519 | 2,72,466 | 21.99 Cr |
2,72,466
of 20,519
469 applications
21.99 Cr
|
13.28x |
| TOTAL | 81,58,529 | 57,32,14,536 | 46,258.41 Cr |
57,32,14,536
26,07,168 applications
46,258.41 Cr
|
70.26x |
Last Updated: 08 Sep 2026, 01:37 PM
Molbio Diagnostics IPO Basis of Allotment
Final figures published by the registrar, after technical rejections. Allotment price ₹807, employees ₹731.
| Category | AppsApplications | Shares Applied | Shares Allotted | GotAllottees | Odds |
|---|---|---|---|---|---|
|
QIB
75.13x subscribed
|
172 |
43,67,29,734
₹35,244 Cr
|
58,12,862
75.13x subscribed
|
0 | -- |
|
Ex. Anchor
Ex. Anchor
|
139 | 43,30,74,060 | 23,25,145 · 186.26x | 0 | -- |
|
Anchor
Anchor Investors
|
33 | 36,55,674 | 34,87,717 · 1.05x | 22 | 1 in 1.51 in 1.5 |
|
NII (HNI)
49.62x subscribed
|
1,52,244 |
8,65,32,732
₹6,983 Cr
|
17,43,860
49.62x subscribed
|
6,919 | 1 in 221 in 22 |
|
bNII >₹10L
bNII — above ₹10 Lakh
|
46,229 | 5,89,27,014 | 11,62,573 · 50.69x | 4,613 | 1 in 101 in 10 |
|
sNII <₹10L
sNII — below ₹10 Lakh
|
1,06,015 | 2,76,05,718 | 5,81,287 · 47.49x | 2,306 | 1 in 461 in 46 |
|
Retail
12.65x subscribed
|
24,54,316 |
5,14,66,284
₹4,153 Cr
|
40,69,005
12.65x subscribed
|
2,26,055 | 1 in 111 in 11 |
|
Employees
1.95x subscribed
|
469 |
39,942
₹2 Cr
|
20,519
1.95x subscribed
|
469 | AllAll allotted |
|
TOTAL
49.35x subscribed
|
26,07,201 | 57,47,68,692 |
1,16,46,246
49.35x subscribed
|
2,33,443 | 1 in 111 in 11 |
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 7.7% for a single lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 186.39x. This often signals long-term confidence from professional funds.
Day-wise Subscription History
Subscription trends over the last 3 days
| Date | Total | ||
|---|---|---|---|
|
12 Aug 2026
DAY 3
|
70.26x
|
||
|
QIB
186.39x
BHNI
50.82x
SHNI
47.76x
Retail
12.96x
Employee
13.28x
|
|||
|
11 Aug 2026
DAY 2
|
3.11x
|
||
|
QIB
1.39x
BHNI
4.31x
SHNI
7.01x
Retail
3.18x
Employee
4.78x
|
|||
|
10 Aug 2026
DAY 1
|
0.83x
|
||
|
QIB
1x
BHNI
0.7x
SHNI
0.8x
Retail
0.77x
Employee
2.12x
|
|||
IPO Guru on Android
Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.
Anchor Investor Allocation
Breakdown of shares allotted to anchor investors before the IPO opening
Molbio Diagnostics IPO Allotment Probability
Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.
What Does This Subscription Data Mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently Asked Questions
What is the current subscription status of Molbio Diagnostics IPO?
As of IPO close date (12 Aug, 2026), the Molbio Diagnostics IPO is subscribed 70.26x times. Retail category is 12.96x, and NII is 49.8x subscribed.
When is the allotment date for Molbio Diagnostics IPO?
The allotment for Molbio Diagnostics IPO is expected to be finalized on 13 August, 2026.
What is the GMP of Molbio Diagnostics?
The Grey Market Premium (GMP) for Molbio Diagnostics is currently ₹120, indicating a potential listing gain of 14.87%.
When will Molbio Diagnostics IPO list on the stock market?
Molbio Diagnostics is scheduled to list on BSE and NSE on 17 August, 2026.
What are the chances of getting allotment in Molbio Diagnostics IPO?
The retail category is oversubscribed at 12.96x, meaning allotment is by lottery. Statistically, approximately 1 in 13 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 186.39x mean for Molbio Diagnostics IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 186.39x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Molbio Diagnostics IPO allotment status?
After the allotment date (13 Aug, 2026), you can check your Molbio Diagnostics IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Molbio Diagnostics IPO Further
Track every stage of this IPO from subscription to listing: